Larotrectinib
Larotrectinib (Vitrakvi, LOXO-101, ARRY-470) is an ATP-competitive, oral administered and highly selective inhibitor of the tropomyosin-related kinase (TRK) family receptors.
Supplier | Selleck Chemicals |
---|---|
Product # | S5860 |
Sku # | S5860-5mg |
Pricing | 5mg, $99.00 |